News

May 11, 2017

Intensity-modulated Radiotherapy May Be Safer, More Effective in Treating Mesothelioma

News

Intensity-modulated radiotherapy (IMRT) was found to be less dangerous and more effective than standard conformal radiotherapy in treating malignant pleural mesothelioma (MPM), a recent study reports. A team of researchers ... Read more

May 10, 2017May 10, 2017

Orally Available Small Molecule Inhibitor of SCD1 Targets Mesothelioma Metabolism, Study Finds

News

New preclinical research shows that T-3764518, an orally available small molecule inhibitor of stearoyl-CoA desaturate-1 (SCD1), can block tumor growth in colon cancer and mesothelioma cell lines as well as ... Read more

May 9, 2017May 9, 2017

MicroRNA Levels Could Help Distinguish Malignant Mesothelioma from Lung Cancer, Study Reports

News

Analyzing the levels of microRNA (miRNA)-130a in cells collected from pleural effusions, a condition in which fluid accumulates between the thin membranes surrounding the lungs, may help distinguish malignant pleural ... Read more

May 8, 2017May 8, 2017

Doll Factories Pose Occupational Hazard for Asbestos Exposure, Italian Study Finds

News

Women who work in cloth doll factories are exposed to asbestos and therefore have a higher risk of developing mesothelioma, an Italian study found. The report, “Pleural mesothelioma in doll ... Read more

May 5, 2017May 5, 2017

Asbestos-disease Groups Blast 7 Producer Countries’ Bid to Keep Profits Rolling in

News

Seven countries that mine asbestos have prevented a form of it known as chrysotile asbestos from being added to the United Nations Rotterdam Convention‘s list of substances that are so hazardous that ... Read more

May 4, 2017

Electron Microscopy Still a Valuable Tool for Diagnosing Mesothelioma, Researchers Argue

News

Despite advances in diagnostic tools available to scientists, electron microscopy (EM) remains important in the diagnosis of many diseases, including malignant pleural mesothelioma (MPM). This is according to an article ... Read more

May 3, 2017May 3, 2017

Selecta Licenses LMB-100 for Combination Tests with SVP-Rapamycin in Mesothelioma, Other Cancers

News

Selecta Biosciences has licensed to use and test the experimental anti-cancer drug LMB-100 from the Center for Cancer Research (CCR) at the National Cancer Institute (NCI). The agreement promotes additional development ... Read more

May 2, 2017

Checkpoint Molecule Measurements Not Reliable for Mesothelioma Research, Editorial Argues

News

Examining the presence of PD-L1 molecules in a tumor as a test to predict if therapy with immune checkpoint inhibitors will work is a highly controversial area in this field ... Read more

May 1, 2017

Gene Could Become Path to Mesothelioma Therapies, Study Reports

News

A gene known as platelet-derived growth factor receptor beta (PDGFRB) could become the basis of therapies for malignant pleural mesothelioma (MPM), according to an early preclinical study. The research, “Inhibition ... Read more

April 28, 2017

Chemotherapy Prolongs Lives of Mesothelioma Patients Who Relapsed Following Surgery

News

A Japanese study of patients with malignant pleural mesothelioma (MPM) who relapsed after surgery showed that additional chemotherapy after relapse prolonged their lives. The study, “Post-recurrence chemotherapy for mesothelioma patients ... Read more